Universal school-based mental health promotion in Vietnam: a critical appraisal of a health-economic evaluation.

IF 2.2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES
Afschin Gandjour
{"title":"Universal school-based mental health promotion in Vietnam: a critical appraisal of a health-economic evaluation.","authors":"Afschin Gandjour","doi":"10.1080/14737167.2026.2691992","DOIUrl":null,"url":null,"abstract":"<p><p>A recent cost-utility analysis modeled the long-term cost-effectiveness of a universal, teacher-delivered school mental health program for adolescents in Vietnam. This key paper evaluation discusses how modeling choices-particularly the translation of short-term symptom outcomes into model-ready risk reductions, the handling of dichotomized thresholds, and assumptions about persistence of benefit-can materially influence long-term cost-effectiveness conclusions. We highlight the importance of distinguishing odds ratios from risk ratios for common outcomes, reporting marginal/population-average risks and risk differences suitable for transition probabilities, and providing distributional information to assess whether apparent benefits are driven by movement around a cut-point. We also discuss how conclusions depend on structural assumptions about waning and the duration of effects, and on the clarity of the costing perspective and included cost components. We suggest reporting and scenario analyses that would improve transparency and strengthen the credibility of long-horizon results.</p>","PeriodicalId":12244,"journal":{"name":"Expert Review of Pharmacoeconomics & Outcomes Research","volume":" ","pages":"1-4"},"PeriodicalIF":2.2000,"publicationDate":"2026-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Pharmacoeconomics & Outcomes Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14737167.2026.2691992","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

A recent cost-utility analysis modeled the long-term cost-effectiveness of a universal, teacher-delivered school mental health program for adolescents in Vietnam. This key paper evaluation discusses how modeling choices-particularly the translation of short-term symptom outcomes into model-ready risk reductions, the handling of dichotomized thresholds, and assumptions about persistence of benefit-can materially influence long-term cost-effectiveness conclusions. We highlight the importance of distinguishing odds ratios from risk ratios for common outcomes, reporting marginal/population-average risks and risk differences suitable for transition probabilities, and providing distributional information to assess whether apparent benefits are driven by movement around a cut-point. We also discuss how conclusions depend on structural assumptions about waning and the duration of effects, and on the clarity of the costing perspective and included cost components. We suggest reporting and scenario analyses that would improve transparency and strengthen the credibility of long-horizon results.

越南普遍以学校为基础的心理健康促进:对健康经济评价的批判性评价。
最近的一项成本效用分析模拟了越南一项普遍的、由教师授课的青少年学校心理健康项目的长期成本效益。这篇关键的论文评估讨论了建模选择——特别是将短期症状结果转化为模型准备的风险降低、处理二分类阈值和关于效益持久性的假设——如何对长期成本效益结论产生实质性影响。我们强调区分常见结果的优势比和风险比的重要性,报告人口平均(边际)风险和适合转移概率的风险差异,并提供分布信息来评估是否明显的利益是由切点周围的运动驱动的。我们还讨论了结论如何依赖于对影响的减弱和持续时间的结构性假设,以及成本观点和包括成本组成部分的清晰度。我们建议进行报告和情景分析,以提高透明度并加强长期结果的可信度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Expert Review of Pharmacoeconomics & Outcomes Research
Expert Review of Pharmacoeconomics & Outcomes Research HEALTH CARE SCIENCES & SERVICES-PHARMACOLOGY & PHARMACY
CiteScore
4.00
自引率
4.30%
发文量
68
审稿时长
6-12 weeks
期刊介绍: Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书